NeuroSense Therapeutics (NASDAQ:NRSN) filed to sell 5.28M ordinary shares for holders. This preliminary prospectus is not an offer to sell. Filing

More on NeuroSense Therapeutics

NeuroSense Therapeutics shares climbed on $5M private placement Seeking Alpha's Quant Rating on NeuroSense Therapeutics Historical earnings data for NeuroSense Therapeutics Financial information for NeuroSense Therapeutics